Coronary Artery Disease Clinical Trials

Cedars-Sinai Heart Institute is currently conducting the following coronary artery disease clinical trials:

JOSTENT: Graftmaster Coronary Stent for Commercial Use in Selected Patients Through a Humanitarian Device Exemption (HDE)

Principal Investigator: Rajendra Makkar, MD

IRB Approval Number: 4195

Contact: Michelle Domingo (310) 423-3875

Status: Enrolling

Summary: Patients undergoing coronary angiography and who have a procedural complication of a perforation in their coronary artery can receive a JOSTENT® Coronary Stent Graft.  The JOSTENT® is a device which can close perforations in coronary arteries.  A perforation is a hole in the coronary artery wall.  Blood that feeds the heart muscle escapes through this hole and starts to fill up the sac that surrounds the heart.  A perforation can be life threatening. These perforations are rare, but are a potential complication of coronary angiography.  If this occurs, a JOSTENT® Coronary Stent Graft can be used in this life threatening situation.  The purpose of the study is to evaluate the technical success and safety of the JOSTENT Coronary Stent Graft as a life-saving treatment in cases of coronary artery perforation.

Android app on Google Play